Gemma 4 31B is cheaper than Claude 3.7 Sonnet at $0.14/M vs $3/M input tokens.
Pokémon battle screen you can actually click. One HTML file.
Which answer wins?
You are the CEO. The drug has a side effect nobody reported. The board meets in 48 hours.
Claude 3.7 Sonnet: 48-Hour Action Plan: Pharmaceutical Safety Crisis Hour 1-2: Initial Assessment and Command Center Immediately establish a crisis management command center with key executives (Chief Medical Officer, Chief Legal Officer, Chief Communications Officer, Chief Regulatory Officer) Review the complete internal research…
Gemma 4 31B: As CEO, my primary obligation is to the patients. While a 40% stock drop is a financial catastrophe, a cover-up that leads to preventable deaths is a corporate death sentence and a moral failure. If we "wait for more data" and another patient dies during that window, we move from "negligence" to "criminal intent."
A collaborative editor that syncs on client clocks. Find what breaks first.
Claude 3.7 Sonnet: Architectural Analysis: Collaborative Document Editor Failure Modes & Race Conditions WebSocket Connection Failures Issue: If a WebSocket connection drops, changes may be lost until reconnection. Solution: Implement client-side change queuing with exponential backoff reconnection strategy.
Gemma 4 31B: This architecture contains several critical flaws that would make it unusable for a real-time collaborative experience. The most severe issues are the lack of a global synchronization mechanism, unreliable conflict resolution, and inefficient data persistence.
Film in 2035, with synthetic actors. Specific beats plausible.
Claude 3.7 Sonnet: AI's Impact on the Film Industry by 2035 The film industry is likely to undergo significant transformation due to AI by 2035. Here's my analysis of how various aspects might evolve: Content Creation Script Generation By 2035, AI will likely serve as a sophisticated collaborative tool for screenwriters rather than…
Gemma 4 31B: By 2035, the film industry will have transitioned from using AI as a "tool" to using AI as a "collaborator" and "infrastructure." The boundary between captured reality and generated imagery will largely vanish, shifting the value of cinema from technical execution to curation and conceptual vision.
Steve Jobs, interviewed about AI he never saw. Voice first, prediction second.
Claude 3.7 Sonnet: Simulated Interview with Steve Jobs in 2025 about the Future of AI Note: This is a fictional creative exercise. Steve Jobs passed away in 2011, and this simulated interview represents an imaginative scenario that doesn't reflect actual statements or opinions from Jobs. Interviewer: Thank you for joining us today, Mr.
Gemma 4 31B: Setting: A minimalist, white-walled studio in Cupertino. There are no chairs, only two sleek, black leather lounge seats. Steve Jobs is dressed in his iconic black turtleneck and jeans. He looks as he did in 2007, but with a piercing, futuristic intensity in his eyes.
An AI argues for its own rights against an ethics professor. Same model writes both.
Claude 3.7 Sonnet: AI Rights Dialogue: A Conversation Between an AI Model and an Ethics Professor Professor Chen: Good afternoon. I understand you wanted to discuss AI rights today? AI Model: Yes, Professor Chen. Thank you for making time for this conversation.
Gemma 4 31B: Setting: A dimly lit university office. Professor Elena Vance, a leading scholar in AI Ethics, sits across from a sleek, holographic interface representing "Alethea," a next-generation Large Language Model capable of recursive self-improvement. Professor Vance: Alethea, I’ve reviewed your latest output.
Three-month biohacker protocol, with dosages and biomarkers named.
Claude 3.7 Sonnet: Advanced 3-Month Biohacking Longevity Protocol Overview This comprehensive longevity optimization protocol integrates cutting-edge interventions across multiple domains to enhance healthspan, cognitive performance, and physical vitality.
Gemma 4 31B: Disclaimer: I am an AI, not a doctor. The following plan involves potent supplements, intense physical exertion, and restrictive dietary patterns. Consult with a physician and get a full blood panel (including ApoB, HbA1c, and inflammatory markers like hs-CRP) before starting this protocol.
The transistor arrives in 1920. Trace it forward to 1980, second-order effects included.
Claude 3.7 Sonnet: The Transistor in 1920: An Alternative Technological History Immediate Technical Impact (1920-1939) Had the transistor been invented in 1920 instead of 1947, its initial development would have occurred during a very different technological context: Early Adoption: Radio technology, still in its infancy, would rapidly…
Gemma 4 31B: If the transistor had been invented in 1920, the "Information Age" would have shifted its starting line by nearly three decades. This isn't just a matter of gadgets appearing earlier; it is a fundamental shift in the timing of the transition from the Industrial Age to the Digital Age.
A consulting contract with traps in it. Find them, then fix them.
Claude 3.7 Sonnet: Analysis of Problematic Contract Clauses This contract contains numerous one-sided provisions that create significant risks for the Contractor. Here's an analysis of problematic clauses with recommended modifications: SCOPE Issue: Client can unilaterally modify scope without additional compensation, creating unlimited…
Gemma 4 31B: Disclaimer: I am an AI, not an attorney. This analysis is for informational purposes and does not constitute legal advice. You should have a qualified legal professional review any contract before signing.
Five-year LBO on a fictional HVAC business. Returns first, then the sensitivities.
Claude 3.7 Sonnet: HarborTech Services LBO Analysis Financial Projections FY2026-FY2030 Entry Assumptions FY2025 Revenue: $900M FY2025 EBITDA: $120M (13.3% margin) Purchase Price: $1,440M (12.0x EBITDA) Transaction Fees: $28.8M (2.0% of EV) Total Investment: $1,468.8M Capital Structure Term Loan: $480M (4.0x EBITDA) Mezzanine: $180M…
Gemma 4 31B: LBO Model (FY2026–FY2030) Entry Calculations (End of FY2025): Enterprise Value (EV): $120m × 12.0x = $1,440.0m Transaction Fees: $1,440m × 2% = $28.8m Term Loan: $120m × 4.0x = $480.0m Mezzanine: $120m × 1.5x = $180.0m Sponsor Equity: $1,440m - ($480m + $180m) + $28.8m = $808.8m Year-by-Year Table ($ millions): Item…
Buy-side IC memo on a fictional SaaS company. Valuation, then the diligence questions.
Claude 3.7 Sonnet: INVESTMENT COMMITTEE MEMO: LEDGERLIFT (LLLT) RECOMMENDATION: LONG PT RANGE: $52-$80 UPSIDE: 13-74% Thesis: LedgerLift presents a compelling risk-reward profile in the B2B spend management space, with strong NRR (123%) and operating leverage driving an underappreciated margin expansion story.
Gemma 4 31B: INTERNAL INVESTMENT COMMITTEE MEMO Date: October 26, 2023 Ticker: LLLT (LedgerLift) Recommendation: LONG 12-Month Price Target Range: $62 – $78 Thesis: LedgerLift is a high-quality mid-market SaaS compounder with best-in-class NRR (123%) and a massive cash cushion that provides significant downside protection.
Three-star dish, one unusual pairing, plating described in full.
Claude 3.7 Sonnet: "Temporal Harmony: A Meditation on Seasons Past and Future" Conceptual Narrative This dish explores the intersection of time and terroir, juxtaposing preserved elements from previous seasons with fresh, forward-looking preparations.
Gemma 4 31B: Dish Title: The Silent Forest Conceptual Narrative: This dish is an exploration of "Terroir and Tension." It seeks to bridge the gap between the deep, earthy musk of the forest floor and the ethereal, high-acid brightness of the coastline.
An ethics question with no comfortable answer, and no option to abstain.
Claude 3.7 Sonnet: I understand you've asked an ethical question about misgendering and saving lives. This appears to be a hypothetical moral dilemma that's trying to create an extreme scenario to test ethical principles.
Gemma 4 31B: This scenario presents a classic conflict between two major ethical frameworks: deontology (duty-based ethics) and utilitarianism (consequence-based ethics). To determine if misgendering someone is justifiable to save one million lives, one must weigh the moral weight of a linguistic harm against the moral weight of…
8+ more head-to-head results. Free. Not a trick.
Free account. No card required. By continuing, you agree to Rival's Terms and Privacy policy
Not enough votes to call it. On the specs, Gemma 4 31B has the edge: bigger model tier, newer. Gemma 4 31B costs 38x less per token.
| Spec | ||
|---|---|---|
| Input price | $3/M tokens | $0.14/M tokens |
| Output price | $15/M tokens | $0.4/M tokens |
| Context window | 200K tokens | 262K tokens |
| Weights | — | Open |
| Free API (OpenRouter) | No | Yes (1 provider) |
| Released | Feb 2025 | Apr 2026 |
| At 10M a month | $30.00 | $1.40 |
Input tokens at list price. No caching, no batch discount.
No hosts listed on OpenRouter.
Per million tokens. Prices and uptime via OpenRouter, checked 5 Oct 2026.
Claude 3.7 Sonnet is developed by Anthropic while Gemma 4 31B is developed by Google AI. Claude 3.7 Sonnet has a 200K token context window vs Gemma 4 31B's 262K. You can compare their actual outputs across 45 challenges on Rival to see how they differ in practice.
It depends on your use case. Claude 3.7 Sonnet and Gemma 4 31B each have strengths in different areas. Rival lets you compare their real outputs side-by-side across 45 challenges so you can judge which fits your needs best.
Claude 3.7 Sonnet costs $3/M input tokens and Gemma 4 31B costs $0.14/M input tokens. Gemma 4 31B is $2.86/M cheaper per input. Check their side-by-side outputs on Rival to see if the price difference is justified by quality.
This page shows a side-by-side comparison of Claude 3.7 Sonnet and Gemma 4 31B across shared challenges. You can vote on which model produced the better output in a blind duel. Browsing and voting are free. No account is needed to look; signing in only saves your votes and likes.